129 related articles for article (PubMed ID: 12040755)
1. The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma.
Zabel A; Thilmann C; Milker-Zabel S; Schlegel W; Zuna I; Wannenmacher M; Debus J
Strahlenther Onkol; 2002 Apr; 178(4):187-91. PubMed ID: 12040755
[TBL] [Abstract][Full Text] [Related]
2. Comparison of forward planned conformal radiation therapy and inverse planned intensity modulated radiation therapy for esthesioneuroblastoma.
Zabel A; Thilmann C; Zuna I; Schlegel W; Wannenmacher M; Debus J
Br J Radiol; 2002 Apr; 75(892):356-61. PubMed ID: 12000695
[TBL] [Abstract][Full Text] [Related]
3. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.
Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826
[TBL] [Abstract][Full Text] [Related]
4. [Esthesioneuroblastoma: A single institution's experience and general literature review].
Lapierre A; Selmaji I; Samlali H; Brahmi T; Yossi S
Cancer Radiother; 2016 Dec; 20(8):783-789. PubMed ID: 27449859
[TBL] [Abstract][Full Text] [Related]
5. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood.
Saran FH; Baumert BG; Khoo VS; Adams EJ; Garré ML; Warrington AP; Brada M
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):43-51. PubMed ID: 12007940
[TBL] [Abstract][Full Text] [Related]
6. Proton therapy for pediatric and adolescent esthesioneuroblastoma.
Lucas JT; Ladra MM; MacDonald SM; Busse PM; Friedmann AM; Ebb DH; Marcus KJ; Tarbell NJ; Yock TI
Pediatr Blood Cancer; 2015 Sep; 62(9):1523-8. PubMed ID: 25820437
[TBL] [Abstract][Full Text] [Related]
7. High dose level radiation therapy for local tumour control in esthesioneuroblastoma.
Guedea F; Van Limbergen E; Van den Bogaert W
Eur J Cancer; 1994; 30A(12):1757-60. PubMed ID: 7880600
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy alone for local tumour control in esthesioneuroblastoma.
Benfari G; Fusconi M; Ciofalo A; Gallo A; Altissimi G; Celani T; De Vincentiis M
Acta Otorhinolaryngol Ital; 2008 Dec; 28(6):292-7. PubMed ID: 19205593
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors.
Khoo VS; Oldham M; Adams EJ; Bedford JL; Webb S; Brada M
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):415-25. PubMed ID: 10487565
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
Minniti G; Saran F; Traish D; Soomal R; Sardell S; Gonsalves A; Ashley S; Warrington J; Burke K; Mosleh-Shirazi A; Brada M
Radiother Oncol; 2007 Jan; 82(1):90-5. PubMed ID: 17161483
[TBL] [Abstract][Full Text] [Related]
11. [The experience of treatment of 7 cases of olfactory neuroblastoma].
Zou L; Cheng Q
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 13(2):60-1. PubMed ID: 12564017
[TBL] [Abstract][Full Text] [Related]
12. Which is the most optimal technique to spare hippocampus?-Dosimetric comparisons of SCRT, IMRT, and tomotherapy.
Kothavade V; Jamema SV; Gupta T; Pungavkar S; Upasani M; Juvekar S; Jalali R
J Cancer Res Ther; 2015; 11(2):358-63. PubMed ID: 26148600
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy of esthesioneuroblastoma.
Eich HT; Staar S; Micke O; Eich PD; Stützer H; Müller R
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):155-60. PubMed ID: 11163509
[TBL] [Abstract][Full Text] [Related]
14. Esthesioneuroblastoma of the nasal cavity.
Hollen TR; Morris CG; Kirwan JM; Amdur RJ; Werning JW; Vaysberg M; Mendenhall WM
Am J Clin Oncol; 2015 Jun; 38(3):311-4. PubMed ID: 23822985
[TBL] [Abstract][Full Text] [Related]
15. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy of esthesioneuroblastoma].
Strnad V; Grabenbauer GG; Dunst J; Sauer R
Strahlenther Onkol; 1994 Feb; 170(2):79-84. PubMed ID: 8108785
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
[TBL] [Abstract][Full Text] [Related]
18. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience.
Polin RS; Sheehan JP; Chenelle AG; Munoz E; Larner J; Phillips CD; Cantrell RW; Laws ER; Newman SA; Levine PA; Jane JA
Neurosurgery; 1998 May; 42(5):1029-37. PubMed ID: 9588547
[TBL] [Abstract][Full Text] [Related]
19. Esthesioneuroblastoma: the role of adjuvant radiation therapy.
Foote RL; Morita A; Ebersold MJ; Olsen KD; Lewis JE; Quast LM; Ferguson JA; O'Fallon WM
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):835-42. PubMed ID: 8244813
[TBL] [Abstract][Full Text] [Related]
20. Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms.
Perks JR; Jalali R; Cosgrove VP; Adams EJ; Shepherd SF; Warrington AP; Brada M
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):507-13. PubMed ID: 10487578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
